I have financial relationships to disclose Consultant for: st Jude, Boston, Sorin, Biotronik, Medtronic, Sanofi, Merck, Menarin Research support
|
|
- Kevin Leonard
- 5 years ago
- Views:
Transcription
1 I have financial relationships to disclose Consultant for: st Jude, Boston, Sorin, Biotronik, Medtronic, Sanofi, Merck, Menarin Research support from: st Jude, Boston, Sorin, Biotronik, Medtronic, Sanofi, Merck, Menarin
2 Atrial Fibrillation and Sports. Hospital Clinic. Universitat de Barcelona
3 1777 competitive athletes without heart disease Mean age 24± 6 years Mean age at most recent assessment 33±6 mean time of sports involvement 6 years 61 % continued with the training during FU Pellicia et al. JACC 2005
4 In the thirties < 0.5% Pellicia et al. JACC 2005
5 Pellicia et al. JACC 2005
6 Lone atrial fibrillation in Marathon runners Hospital Clinic. Thorax Institute. University of Barcelona, Hospital del Mar. Autonomous University of Barcelona Institut Municipal Investigacions Mèdiques IMIM. Barcelona. Molina et al. Europace 2008
7 Methods 270 healthy men that ran the marathon in Barcelona in Control group: 305 healthy sedentary men < 300 Kcal/day of physical activity, recruited at the REGICOR study
8 In the forties 9/183 (5%) Molina et al. Europace 08
9 Lone atrial fibrillation in Marathon runners Adjusted for age and systolic blood pressure
10 In the sixties 15-18% Grimsmo J. Eur J Cardiovasc Prev Rehabil 17:
11 Athletes or vigorous exercise? Is there a threshold?
12 16921 participants at the Physicians Health Study Healthy individuals 12 years follow up
13
14
15 70 patients with lone AF younger than 65y. Regular sport practice 65% among patients with AF and 15% in the general male population of individuals younger than 65 in Catalonia (REGICOR study)
16 Hospital Clínic. University of Barcelona. Institut Municipal d Investigacions Mèdiques de Barcelona. Int J Cardiol 2005
17 Logistic Regression Analysis Vagal Atrial Fibrillation Cases/Controls OR (95% CI) P Sport Practice 17/ ( ) 0.09 Current Sport Practice 6/ ( ) Lifetime hours hours 3/ (0.25-7) NS hours 7/ ( ) Current practice > 1500 hours (3 hours/week, 10 years 6/ ( ) 0.016
18 Is sports related lone AF a familial disease?
19 Familial Atrial Fibrillation and sports: hypothesis Dose related risk of AF in sports goes against a familial disease Genetic forms have a high penetrance and does not need the trigger effect of sport Familial forms of AF are very uncommon and a family history is rarely seen. Athletes show deep structural changes, that may explain AF withouth the need of other etiologic factors.
20 Genetic Predisposition or Genetic Disease Atrial fibrillation as a monogenic disease Atrial firillation associated with other monogenic diseases Genetic predispostion to acquired atrial fibrillation
21 ATRIAL FIBRILLATION AS A MONOGENIC DISEASE Historical Perspective Wolff L. N Engl J Med Gould WL Arch Int Med 1957 Phair WB Canad Med Ass 1963 Derrida JP et al Nouv Pres Med 1976 Wen-tai Y Chin Med J 1983 Ardiaca A et al Rev Esp Card 1987
22 I:1 I:2 FAMILIAL ATRIAL FIBRILLATION REGION SHARED ON 10q2 AFFECTED NON AFFECTED DEAD Brugada R et al NEJM, 1997
23 FAMILIAL ATRIAL FIBRILLATION CLINICAL FEATURES Mean Age of Diagnosis 18 years Range in Age of Diagnosis in utero-35 years Echocardiogram Normal Patients with Chronic AF 51/52 Asymptomatic 36/52 Heart rate bpm Brugada R et al NEJM, 1997
24 Chen YH, et al. Science 2003
25 Gussak et al. Cardiology 2000 Hong et al. JCE, 2005
26
27 Clinical Implications Each family appears to have its own gene No change in clinical approach Penetrance appears high
28 From: Association Between Familial Atrial Fibrillation and Risk of New-Onset Atrial Fibrillation JAMA. 2010;304(20): doi: /jama Date of download: 8/18/2012 Copyright 2012 American Medical Association. All rights reserved.
29 From: Association Between Familial Atrial Fibrillation and Risk of New-Onset Atrial Fibrillation JAMA. 2010;304(20): doi: /jama Date of download: 8/18/2012 Copyright 2012 American Medical Association. All rights reserved.
30 Physical activity, height and left atrial size are independent risk factors for lone atrial fibrillation in middle aged healthy individuals - Thorax Institute. Hospital Clinic, University of Barcelona - IMIM. Institut Municipal de Investigació Mèdica. Barcelona Mont L, Tamborero D, Elosua R, Molina I, Collvinent B, Sitges M, Vidal B, Scalise A, Tejeira A, Berruezo and Brugada J on behalf of the GIRAFA (Grup Integrat de Recerca en FA) investigators Mont et al. Europace 2008
31 Methods Design: Prospective, case-control study Population: 107 consecutive patients younger 18 to 65 Recent onset Lone AF, seen at the emergency room (> 48 hours). Controls: 1:1 age and sex matched controls
32 Demographic characteristics Patients N=107 Controls N= 107 Age (years) 48.0± ±10.2 Male sex (%) 74 (69%) 74 (69%) Smoking (%) 53 (50%) 53 (50%) Paroxysmal/Persistent AF (%) 61 (57%) / 46 (43%) -- Vagal AF (%) 75 (70%) -- First AF episode/ recurrent AF 46 (43%) / 61(57%) -- Number of AF episodes 4.5± AF duration (hours) 15.4±
33 Adjusted Odds ratios and 95% IC of lone AF form heavy physical activity, height and LA AP diameter Odds ratio (95% confidence interval) Cumulated intense physical activity P value 0 hours hours 1.77 ( ) > hours 7.31 ( ) Height ( ) ( ) Left atrial anteroposterior ( ) diameter (mm)
34 Sustained Endurance Training Creates a Substrate for Atrial Fibrillation in Rats Hospital Clínic. University of Barcelona Montreal Heart Institute Begoña Benito Gemma Gay Eduard Guasch Valeria Sirenko David Tamborero Anna Serrano Lluis Mont Benito et al. Circulation 2011 Sophie Cardin Yanfen Shi Patrick Lawler Ange Maguy Jean-Claude Tardif Nathalie L Heureux Chantal St-Cyr Audrey Bonard Stanley Nattel
35 Training Protocol 4 weeks 8 weeks 16 weeks Rest for 3 days Sacrifice
36 Echocardiographic data after 16 weeks of training sedentary exercise IVS thickness (cm) LV diameter (cm) 3.0 ± ± 0.1 *** 14.3 ± ± 0.3 *** LV mass (g) 18.1 ± ± 0.7 *** LA diam (SYST) LA diam (DIAST) 9.2 ± ± 0.3 *** 6.4 ± ± 0.2 * Adjusted for BSA
37 ECG parameters 16 weeks CTL (n=18) Ex (n=17) HR (bpm) 346 ± ± 11 ** PR interval (ms) 56.4 ± ± 1.8 QRS duration (ms) 23.1 ± ± 0.4 QTc interval (ms) (Bazett s) 224 ± ± 4
38 EPS parameters CTL (n=15) Ex (n=14) EP parameters Sinus cycle length (ms) ± ± 5.8 ** SN recovery time (ms) ± ± 7.1 Anterograde Wenck (ms) Atrial refractory period (ms) ± ± 4.5 ** 42.9 ± ± 1.0
39 Inducible arrhythmias Mean duration: 8.7 ± 2.0 min *
40 Protein expression of fibrotic markers in atria: Mean ± SEM;* p<0.05 (n CTL=6, n Ex=8)
41 Atrial fibrosis RA LA Ex CTL Mean ± SEM. * p<0.05; ** p<0.01; *** p<0.001
42 Summary of mechanisms Chronic high-level exercise Hemodynamic effects: Increased vagal tone Atrial overload Atrial enlargement Atrial fibrosis ATRIAL FIBRILLATION
43 Summary AF related to sports seems to be the consequence of atrial remodelling and increased vagal tone. Monogenic AF seems to be a high penetrance and not particularly linked to sport practice A genetic predisposition may be present in certain individuals.
Endurance Exercise and Cardiovascular Health
Endurance Exercise and Cardiovascular Health Professor Sanjay Sharma St George s University of London St George s Hospital NHS Trust sasharma@sgul.ac.uk @SSharmacardio Conflicts/Disclosures: None Objectives
More informationDevice Diagnostics and Stroke Prevention: State of the Art
Device Diagnostics and Stroke Prevention: State of the Art Ass. Prof. Dr. Carsten W. Israel Dept. of Cardiology Evangelical Hospital Bielefeld Germany C.W.Israel@em.uni-frankfurt.de Disclosure of Relationships
More informationEndurance training and cardiac arrhythmias
Endurance training and cardiac arrhythmias Myocardial and autonomic alterations under endurance training Federico Lombardi, MD, FESC Cardiologia, Osp. San Paolo D.M.C.O. University of Milan Milan, Italy
More informationOlivier CAZORLA. Effet délétère de l exercice sur la fonction cardiaque: modèles animaux
Olivier CAZORLA Physiologie et Médecine Expérimentale du cœur et des muscles PHYMEDEXP INSERM U1046, CNRS UMR9214, Université de Montpellier CHU Arnaud de Villeneuve Stress physiologique et physiopathologique:
More informationLong-Term Atrial Fibrillation Progression: What We Know in 2014
Long-Term Atrial Fibrillation Progression: What We Know in 2014 Advances in Cardiac Arrhythmias and Great Innovations in Cardiology XXVI Giornate Cardiologiche Torinesi Turin, 23-25 October 2014 Davide
More informationHow to prevent unecessary right ventricular pacing
How to prevent unecessary right ventricular pacing Jens Cosedis Nielsen, MD, PhD, DMSci Dept of Cardiology, Aarhus University Hospital, Skejby, Denmark June 27, 2011, Europace Madrid Conflicts of interest
More informationThe Athletic Heart Takes Shape: Overview of Cardiac Remodeling Rory B. Weiner, MD
The Athletic Heart Takes Shape: Overview of Cardiac Remodeling Rory B. Weiner, MD Cardiovascular Performance Program, MGH Assistant Professor of Medicine, Harvard Medical School Outline Athlete s Heart
More informationAtrial fibrillation and atrial flutter in athletes
OPEN ACCESS 1 Arrhythmia Unit, Department of Cardiology and Cardiovascular Surgery, University of Navarra, Navarra, Pamplona, Spain 2 Thorax Institute, Hospital Clínic, University of Barcelona, Institut
More informationApril 22, 2017 Abraham Rothman, MD
April 22, 2017 Abraham Rothman, MD University of Nevada School of Medicine } Definitions } Adults } Children } Heart beats } Children and adolescents who want to participate in intensive exercise. } Just
More informationContinuous ECG telemonitoring with implantable devices: the expected clinical benefits
Continuous ECG telemonitoring with implantable devices: the expected clinical benefits C. W. Israel, M.D. Dept. of Cardiology Evangelical Hospital Bielefeld Germany Carsten.Israel@evkb.de Declaration of
More informationExercise Cardiomyopathy
Exercise Cardiomyopathy Aaron L. Baggish MD, F.A.C.C., F.A.C.S.M. Cardiovascular Performance Program Division of Cardiology Massachusetts General Hospital Boston, MA Conflicts: None Athletic Affiliations:
More informationFrançois Carré Hôpital Pontchaillou -INSERM UMR1099-Université Rennes 1
Normal electrocardiogram variants in Athletes François Carré Hôpital Pontchaillou -INSERM UMR1099-Université Rennes 1 Disclosures No disclosure of interest concerning this lecture The cardiovascular sport
More informationDebate PRO. Dronedarone is an important drug in the management of paroxysmal atrial fibrillation. John Camm
ESC ICM - Internationales Congress Center München 2012 Atrial Fibrillation Controversies in Medical Treatment Debate Dronedarone is an important drug in the management of paroxysmal atrial fibrillation
More informationSudden Death in Athletes: What is the role of ECG Screening?
Sudden Death in Athletes: What is the role of ECG Screening? Byron K. Lee MD Professor of Medicine Director of EP Laboratory leeb@medicine.ucsf.edu Division of Cardiology Cardiac Electrophysiology Arrhythmias,
More informationExercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart.
Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart. Hanne Rasmusen Consultant cardiologist, PhD Dept. of Cardiology Bispebjerg University Hospital
More informationAblation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation
Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation 25 October 2008 Update in Electrocardiography and Arrhythmias Zian H. Tseng, M.D., M.A.S. Assistant Professor
More informationSudden Cardiac Death in Sports: Causes and Current Screening Recommendations
Sports Cardiology Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations Domenico Corrado, MD, PhD Inherited Arrhytmogenic Cardiomyopathy Unit Department of Cardiac, Thoracic and
More informationARISTOTLE UNIVERSITY OF THESSALONIKI, GREECE SPORTS MEDICINE LABORATORY ΑΡΡΥΘΜΙA KAI SPORTS TO SCREEN OR NOT TO SCREEN
ARISTOTLE UNIVERSITY OF THESSALONIKI, GREECE SPORTS MEDICINE LABORATORY DIRECTOR: PROF. A. DELIGIANNIS ΑΡΡΥΘΜΙA KAI SPORTS TO SCREEN OR NOT TO SCREEN EVANGELIA KOUIDI CARDIOLOGIST PROFESSOR OF SPORTS MEDICINE
More informationAtrial Fibrillation and Fibrosis: Still a strict link? Johannes Brachmann
Klinikum Coburg Atrial Fibrillation and Fibrosis: Still a strict link? Johannes Brachmann Prof. Dr. med. J. Brachmann Bologna 16 th February 2017 Disclosures Study Grants: Biotronik, Medtronic, SJM, Abbott,
More informationInterpretation and Consequences of Repolarisation Changes in Athletes
Interpretation and Consequences of Repolarisation Changes in Athletes Professor Sanjay Sharma E-mail sasharma@sgul.ac.uk @SSharmacardio Disclosures: None Athlete s ECG Vagotonia Sinus bradycardia Sinus
More informationIs Atrial Fibrillation preventable?
Heart Rhythm Congress, Birmingham, 11 th October 2016 Is Atrial Fibrillation preventable? The interplay between genetic and environmental factors in genesis of AF Andrew Grace University of Cambridge -
More informationAtrial Fibrilation in the WHI and WHISH STAR
Atrial Fibrilation in the WHI and WHISH STAR Marco V. Perez 5/4/2018 Stanford Division of Cardiovascular Medicine WHI Investigator Meeting 2018 Atrial Fibrillation Disorganized Atrium Most Common Arrhyth.
More informationEHRA/EUROPACE 2011 Madrid, Spain June
EHRA/EUROPACE 2011 Madrid, Spain June 26.-29.2011 Implementing modern management in atrial fibrillation patients Proceedings from the 3rd AFNet/EHRA consensus conference EHRA Special Session Different
More informationHistorical Notes: Clinical Exercise Testing in the Athlete. An Efficient Heart. Structural Changes, Cont. Coronary Arteries
Clinical Exercise Testing in the Athlete The athlete s heart Sudden cardiac death in athletes Screening athletes for cardiovascular disease Historical Notes: Giovanni Lancisi (father of cardiology), 17
More informationThere are future perspectives in the pharmacological treatment of arrhythmias
There are future perspectives in the pharmacological treatment of arrhythmias George Andrikopoulos, MD, PhD, FESC, Cardiologist, Director, 1st Department of Cardiology/ Department of Electrophysiology
More informationAtrial fibrillation and advanced age
Atrial fibrillation and advanced age Prof. Fiorenzo Gaita Director of the Cardiology School University of Turin, Italy Prevalence of AF in the general population Prevalence and age distribution in patients
More informationEVALUATION OF ELECTROCARDIOGRAPHIC FINDINGS IN ATHLETES
EVALUATION OF ELECTROCARDIOGRAPHIC FINDINGS IN ATHLETES UNIT OF INHERITED CV DISEASES HEART CENTER OF THE YOUNG AND ATHLETES A DPT OF CARDIOLOGY UNIVERSITY OF ATHENS EVALUATION OF ELECTROCARDIOGRAPHIC
More informationAtrial Fibrillation. Ivan Anderson, MD RIHVH Cardiology
Atrial Fibrillation Ivan Anderson, MD RIHVH Cardiology Outline Definition and Pathophysiology Rate versus rhythm control Rate control thresholds (how much is enough) Anti-coagulation CHADS2VASc score HASBLED
More informationThe Athlete s Heart. Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University
The Athlete s Heart Role of Echo Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University Washington, D.C. Disclosures Grant support (to institution) for Core
More informationThe Role of ACEI and ARBs in AF prevention
The Role of ACEI and ARBs in AF prevention Dr. Sameh Shaheen MD, FESC Prof. of cardiology Ain-Shams university Time course of atrial substrate remodeling in relation to the clinical appearance of AF and
More informationEVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington
EVALUATION OF THE 12 ATHLETE Karen Stout, MD Professor, Medicine and Pediatrics University of Washington NO DISCLOSURES OUTLINE Why evaluate athletes? What s the problem? What evaluation should be done?
More informationTitle: Left atrium size in former elite athletes
Title: Left atrium size in former elite athletes Short title: exercise and left atrium Authors: Fabian Sanchis-Gomar, MD, PhD, a Nuria Garatachea, PhD, a,b Pilar Catalán, MD, c Marta López, MD, d Alejandro
More informationArrhythmia/Electrophysiology. Cardiac Arrhythmogenic Remodeling in a Rat Model of Long-Term Intensive Exercise Training
Arrhythmia/Electrophysiology Cardiac Arrhythmogenic Remodeling in a Rat Model of Long-Term Intensive Exercise Training Begoña Benito, MD*; Gemma Gay-Jordi, PhD*; Anna Serrano-Mollar, PhD; Eduard Guasch,
More informationThe 5 Most Important Things You Need to Know About Atrial Fibrillation. John D. Day, MD
The 5 Most Important Things You Need to Know About Atrial Fibrillation John D. Day, MD Disclosures Consulting with St. Jude Medical, Boston Scientific, and Biotronik The 5 Most Important Things You Need
More informationProf. Samir Morcos Rafla Alexandria Univ. Cardiology Dept.
Obesity as a risk factor for Atrial Fibrillation Prof. Samir Morcos Rafla Alexandria Univ. Cardiology Dept. CardioAlex 2010 smrafla@hotmail.com 1 Obesity has reached epidemic proportions in the United
More informationAtrial Cardiomyopathy is it relevant?
Atrial Cardiomyopathy is it relevant? Dr Carl Shakespeare MD FRCP FACC FESC Consultant Cardiologist Relevance Progressive nature of AF Implications for RF Targeting Risk Factors CHADS vasc scoring? Could
More informationPreventing Sudden Death Current & Future Role of ICD Therapy
Preventing Sudden Death Current & Future Role of ICD Therapy Derek V Exner, MD, MPH, FRCPC, FACC, FAHA, FHRS Professor, Libin Cardiovascular Institute of Alberta Canada Research Chair, Cardiovascular Clinical
More informationRisk Factors for Sudden cardiac Death
Risk Factors for Sudden cardiac Death A. Arenal Arrhythmias in competitive sports Disclosure Conflict of interest Advisory board: Medtronic, Boston Scientific Research grants: Medtronic, Boston Scientific,
More information13/09/2018. The ISSUE Studies. International (Italy & Spain) Study of Syncope of Uncertain Etiology. ISSUE study Pre-defined inclusion cathegories
The Studies Jean-Claude Deharo Aix-Marseille Université, France In Cardiac Electrophysiology Methods and Models Editors: Daniel C. Sigg, Paul A. Iaizzo, Yong-Fu Xiao, Bin He Springer 2010 study Pre-defined
More informationSaudi Heart Association February 22, 2011
Pharmacological Therapy of Atrial Fibrillation: Recent Advances Dr Martin Green Professor of Medicine (Cardiology) University of Ottawa Saudi Heart Association February 22, 2011 Atrial Fibrillation Drugs
More information«Aσθενής με ασυμπτωματικό WPW και παροξυσμική κολπική μαρμαρυγή» Χάρης Κοσσυβάκης Επιμελητής A Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.
«Aσθενής με ασυμπτωματικό WPW και παροξυσμική κολπική μαρμαρυγή» Χάρης Κοσσυβάκης Επιμελητής A Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ» the primary mechanism of SCD in patients with WPW is the rapid conduction
More informationPrevention of Sudden Death in ARVC
ESC Munich, August 29, 2012 Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): Prevention of Sudden Death in ARVC Thomas Wichter, MD, FESC Professor of Medicine - Cardiology Marienhospital Osnabrück
More informationSummary, conclusions and future perspectives
Summary, conclusions and future perspectives Summary The general introduction (Chapter 1) of this thesis describes aspects of sudden cardiac death (SCD), ventricular arrhythmias, substrates for ventricular
More informationThe Athlete s Heart. Critical Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University
The Athlete s Heart Critical Role of Echo Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University Washington, D.C. Disclosures Grant support (to institution)
More informationPost-ablation Management: Drug therapy, Anticoagulation and long-term Monitoring
Catheter Ablation of Atrial Fibrillation: State of the Art Post-ablation Management: Drug therapy, Anticoagulation and long-term Monitoring Dipen Shah Service de Cardiologie Hospital Cantonal de Genève
More informationAblation of persistent AF Is it different than paroxysmal?
Ablation of persistent AF Is it different than paroxysmal? Steven J. Kalbfleisch, MD Medical Director Electrophysiology Laboratory Ohio State University Wexner Medical Center Ross Heart Hospital Columbus,
More informationAF Ablation in Patients with Heart Failure
AF Ablation in Patients with Heart Failure Christian de Chillou, MD, PhD Department of Cardiology University Hospital Nancy, France 28ème Journée Internationale du Centre Cardio-Thoracique de Monaco Monaco,
More informationSABIHA GATI AND SANJAY SHARMA
9 The athlete s heart SABIHA GATI AND SANJAY SHARMA Pasieka/Science Photo Library In this article, the authors highlight the spectrum, magnitude and determinants of the athlete s heart and provide a practical
More informationAtrial fibrillation and stroke. Isabelle C Van Gelder University Medical Center Groningen The Netherlands
Atrial fibrillation and stroke Isabelle C Van Gelder University Medical Center Groningen The Netherlands ESC stroke council Prague January 2018 Content Stroke what is the problem for patients with AF?
More informationCardiovascular Impacts of long-term endurance exercise: Implications of athlete s heart
Cardiovascular Impacts of long-term endurance exercise: Implications of athlete s heart Dr. Gary Mak 麥耀光心臟科專科醫生 IPP of HK Associa4on of Sports Medicine and Sports Science Director of Pro-Cardio Heart Disease
More informationDRS ed Aritmie Cardiache Iper ed Ipocinetiche: la clinica
Corso Multidisciplinare di Aggiornamento La Sindrome delle Apnee Notturne: una sfida diagnostico terapeutica DRS ed Aritmie Cardiache Iper ed Ipocinetiche: la clinica FRANCESCO PERNA, MD, PhD Laboratorio
More informationSubclinical AF: Implications of device based episodes
Subclinical AF: Implications of device based episodes Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC Disclosures: Clinical Trials and Consulting: Medtronic, Boston Scientific
More informationDebate: Asymptomatic Patients with Ventricular Preexcitation Require EP Testing for Risk Stratification. Carlo Pappone, MD, PhD, FACC
Debate: Asymptomatic Patients with Ventricular Preexcitation Require EP Testing for Risk Stratification Carlo Pappone, MD, PhD, FACC The Wolff-Parkinson-White Syndrome Demographics Δ waves detectable on
More informationA Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC
A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC AF Clinical/Referral Challenge Asymptomatic 40% 3 Rx Effective 30% Failed Rx Ablation Atrial fibrillation (AF) is the most common Candidate
More informationThe frontier between normal and abnormal electrocardiogram in athletes
The frontier between normal and abnormal electrocardiogram in athletes ESC Congress 2011 Paris F. Carré University Rennes 1-Pontchaillou Hospital Inserm U642, Rennes - F-35000 Cardiovascular preparticipation
More informationInterventional solutions for atrial fibrillation in patients with heart failure
Interventional solutions for atrial fibrillation in patients with heart failure Advances in Cardiovascular Arrhythmias Great Innovations in Cardiology Matteo Anselmino, MD PhD Division of Cardiology Department
More informationSabri DEMIRCAN Istanbul Bilim University Department of Cardiology
abri DEMIRCN Istanbul Bilim University Department of Cardiology H/CC/HR Guideline for the Management of Patients With trial Fibrillation. J m Coll Cardiol 4;64:46-8. European Heart Journal () 3, 369-49
More informationPhysical Activity and Coronary calcification ADJ ASSOCIATE PROFESSOR TAN SWEE YAW NATIONAL HEART CENTRE SINGAPORE
Physical Activity and Coronary calcification ADJ ASSOCIATE PROFESSOR TAN SWEE YAW NATIONAL HEART CENTRE SINGAPORE Calcium Scores (CACS) Calcium Scores (CACS) Calcium Scores are indicative of the presence
More informationEfficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes
Europace (2010) 12, 30 36 doi:10.1093/europace/eup320 CLINICAL RESEARCH Ablation for Atrial Fibrillation Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes
More informationat least 4 8 hours per week
ECG IN ATHLETS An athlete is defined as an individual who engages in regular exercise or training for sport or general fitness, typically with a premium on performance, and often engaged in individual
More informationHow atrial fibrillation should be treated in the heart failure patient?
Advances in Cardiac Arrhhythmias and Great Innovations in Cardiology Torino, 13/15 Ottobre 2016 How atrial fibrillation should be treated in the heart failure patient? Matteo Anselmino Dipartimento Scienze
More informationProgression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro
Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro Jerónimo Farré MD, Madrid, ES AF: the kingdom of wishful thinking In AF we
More informationAtrial Fibrillation Promotion by Endurance Exercise Demonstration and Mechanistic Exploration in an Animal Model
Journal of the American College of Cardiology Vol. 62, No. 1, 2013 Ó 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2013.01.091
More informationANTIPAF Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation Trial
European Society of Cardiology Hotline Stockholm - Zone K 31 st August 2010 Placebo ARB Kumagai K, et al. JACC 2003 Discussant ANTIPAF Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation Trial
More informationDON T FORGET TO OPTIMISE DEVICE PROGRAMMING
CRT:NON-RESPONDERS OR NON-PROGRESSORS? DON T FORGET TO OPTIMISE DEVICE PROGRAMMING Prof. ALİ OTO,MD,FESC,FACC,FHRS Chairman,Department of Cardiology Hacettepe University Faculty of Medicine,Ankara Causes
More informationAtrial Fibrillation and You
Atrial Fibrillation and You Dr Matthew Fay General Practitioner AFA Medical Advisory Committee Member NHS-Improvement Clinical Lead AF & U Dr Matthew Fay General Practitioner AFA Medical Advisory Committee
More informationAthletes with cardiac disease; dead and buried or chance for resurrection?
Athletes with cardiac disease; dead and buried or chance for resurrection? EuroPRevent 2011 Geneva F. Carré University Rennes 1-Pontchaillou Hospital Inserm U642, Rennes - F-35000 Risk of physical activity
More informationCurrent ECG interpretation guidelines in the screening of athletes
REVIEW ARTICLE 7 How to differentiate physiological adaptation to intensive physical exercise from pathologies Current ECG interpretation guidelines in the screening of athletes Gemma Parry-Williams, Sanjay
More informationCatheter ablation in AF patients with heart failure. What is possible?
Catheter ablation in AF patients with heart failure What is possible? Sébastien Knecht, MD PhD Hôpital cardiologique du Haut L Evêque, Bordeaux HEART FAILURE AND AF Ehrlich. JCE 2002 (13): 399-405, Wang
More informationAthlete s Heart: Clinical Relevance. Athlete's Heart vs. Cardiac Pathology Clinical Approaches. Echo Florida Conflicts of Interest: None
Athlete's Heart vs. Cardiac Pathology Clinical Approaches Echo Florida 2012 Aaron L. Baggish MD Cardiovascular Performance Program Cardiac Ultrasound Laboratory Division of Cardiology Massachusetts General
More informationRational Approach to Improving Cardiac Arrhythmia Therapy. Rational Approach to Improving Cardiac Arrhythmia Therapy
Rational Approach to Improving Cardiac Arrhythmia Therapy Rational Approach to Improving Cardiac Arrhythmia Therapy Stanley Nattel, MD Stanley Nattel, MD DEDICATED TO THE MASTER OF RATIONAL THERAPEUTICS
More informationAthlete s Heart vs. Cardiomyopathy
Athlete s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular Service Line Former Team Cardiologist to the New York Jets
More informationBrazilian Journal of Biomotricity ISSN: Universidade Iguaçu Brasil
Brazilian Journal of Biomotricity ISSN: 1981-6324 marcomachado@brjb.com.br Universidade Iguaçu Brasil Kaur, Kulroop EFFECT OF STRENGTH TRAINING ON LEFT ATRIUM IN WRESTLERS Brazilian Journal of Biomotricity,
More informationAF ABLATION Concepts and Techniques
AF ABLATION Concepts and Techniques Antony F Chu, M.D. Director of Complex Ablation Arrhythmia Services Section Division of Cardiology at the Rhode Island and Miriam Hospital HIGHLIGHTS The main indications
More informationThis is What I do to Improve CRT Response for CRT Non-Responders
This is What I do to Improve CRT Response for CRT Non-Responders Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC Disclosures: Steering Committees (unpaid) and Clinical Trials,
More informationHeart Rate Recovery in association with exercise stress testing
Heart Rate Recovery in association with exercise stress testing Daniel E. Forman, M.D. Director, Exercise Laboratory Brigham and Women s Hospital April 21, 2006 Stress Testing Historical Rationale for
More informationOutline. Many Health Benefits of exercise for all ages. Over age 35 years- drawn to endurance exercise. Risks of exercise
Outline Sports Cardiology In Endurance Athletes AKOMA CME Conference 5-1-14 Anchorage AK Christine E. Lawless, MD, MBA, FACC, FACSM, CAQSM Founder, ACC Sports and Exercise Cardiology Council President-Sports
More informationAtrial Remodeling, Autonomic Tone, and Lifetime Training Hours in Nonelite Athletes
Atrial Remodeling, Autonomic Tone, and Lifetime Training Hours in Nonelite Athletes Matthias Wilhelm, MD a, *, Laurent Roten, MD b, Hildegard Tanner, MD b, Ilca Wilhelm, MD c, Jean-Paul Schmid, MD a, and
More informationRight ventricular adaptation in endurance athletes. António Freitas. No conflict of interest
The role of echocardiography in sports cardiology Right ventricular adaptation in endurance athletes. António Freitas Cardiology Department - Fernando Fonseca Hospital Lisbon Sports Medicine Centre - Lisbon
More informationCatheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes
Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes Francis Marchlinski, MD Richard T and Angela Clark President s Distinguished Professor Director Cardiac Electrophysiolgy University
More informationNormal ECG And ECHO Findings in Athletes
Normal ECG And ECHO Findings in Athletes Dr.Yahya Kiwan Consultant Interventional Cardiologist Head Of Departement Of Cardiology Canadian Specialist Hospital Sinus Bradycardia The normal heartbeat is initiated
More informationDeclaration of conflict of interest. None to declare
Declaration of conflict of interest None to declare Risk management of coronary artery disease Arrhythmias and diabetes Hercules Mavrakis Cardiology Department Heraklion University Hospital Crete, Greece
More informationAtrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology
Atrial Fibrillation: Rate vs. Rhythm Michael Curley, MD Cardiac Electrophysiology I have no relevant financial disclosures pertaining to this topic. A Fib Epidemiology #1 Most common heart rhythm disturbance
More informationVentricular tachyarrhythmias induced by exercise: are they an unsafe clinical pattern?
Ventricular tachyarrhythmias induced by exercise: are they an unsafe clinical pattern? Alessandro Biffi Istitute of Sports Medicine and Science Italian Olympic Commitee Rome, Italy A complex interaction
More informationICD in a young patient with syncope
ICD in a young patient with syncope Konstantinos P. Letsas, MD, FESC Second Department of Cardiology Evangelismos General Hospital of Athens Athens, Greece Case presentation A 17-year-old apparently healthy
More informationDr Navin Chandra Clinical Research Fellow in Cardiology St George s University of London
Dr Navin Chandra Clinical Research Fellow in Cardiology St George s University of London Cardiac Adaptation in Athletes Athletic training for prolonged periods may result in physiological adaptations of
More informationRecurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm
Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm Guy Amit, MD, MPH Soroka University Medical Center Ben-Gurion University of the Negev Beer-Sheva, Israel Disclosures Consultant:
More informationFA et Apnée du Sommeil
FA et Apnée du Sommeil La Réunion Octobre 2017 Pascal Defaye CHU Grenoble-Alpes Obstructive Sleep Apnea and AF Incidence of atrial fibrillation (AF), based on presence or absence of OSA. Cumulative frequency
More informationLeft Atrial Appendage Closure: The Rationale
Left Atrial Appendage Closure: The Rationale JOHN D. HUMMEL, MD DIRECTOR OF CLINCAL ELECTROPHYSIOLOGY RESEARCH PROFESSOR OF CLINICAL INTERNAL MEDICINE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER 1 Disclosures
More informationAnodal Capture in Cardiac Resynchronization Therapy Implications for Device Programming
Anodal Capture in Cardiac Resynchronization Therapy Implications for Device Programming DAVID TAMBORERO,* LLUIS MONT,* ROBERTO ALANIS, ANTONIO BERRUEZO,* JOSE MARIA TOLOSANA,* MARTA SITGES,* BARBARA VIDAL,*
More informationMitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France
Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines Christophe Tribouilloy Amiens, France I have no financial relationships to disclose related
More informationDialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy
Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Evan Adelstein, MD, FHRS John Gorcsan III, MD Samir Saba, MD, FHRS
More informationCatheter Ablation for Treatment of Atrial Fibrillation 2010 and Beyond
Catheter Ablation for Treatment of Atrial Fibrillation 2010 and Beyond John M. Miller, MD Professor of Medicine Indiana University School of Medicine Director, Clinical Cardiac Electrophysiology Krannert
More informationAsymptomatic patient with WPW
Asymptomatic patient with WPW Dimosthenis Avramidis, MD. Arrythmiologist Mitera Children s Hospital Athens Greece Scientific Associate 1st Cardiology Dpt Evangelismos Hospital Athens Greece Preexcitation
More informationHis Bundle Pacing: Where is it going? Kenneth A. Ellenbogen, M.D. Kontos Professor, VCU School of Medicine November 17, 2017
His Bundle Pacing: Where is it going? Kenneth A. Ellenbogen, M.D. Kontos Professor, VCU School of Medicine November 17, 2017 Conflicts Medtronic: Research, Honoraria, Consulting Boston Scientific: Research,
More informationAtrial Fibrillation. Why It s Important. Updated on 2007 / 11 / 23. Microlife Corp ww.microlife.com. Page 1
Atrial Fibrillation Why It s Important Microlife Corp ww.microlife.com Updated on 2007 / 11 / 23 Page 1 CONTENT ORIGINAL PRESENTATION P3 ~ P13 UPDATED ASH ABSTRACT SUBMISSION INFORMATION INTERESTING LINK
More informationJ-wave syndromes: update on ventricular fibrillation mechanisms
J-wave syndromes: update on ventricular fibrillation mechanisms Michael Nabauer University of Munich, Germany 28.8.2011 I have no conflicts of interest ECG labelling by Einthoven Circ 1998 Osborn wave
More informationAthlete s Heart vs. Cardiomyopathy
Athlete s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular Service Line Former Team Cardiologist to the New York Jets
More informationAbnormal ECG patterns and significance in a group of mountaineers
Original Article Abnormal ECG patterns and significance in a group of mountaineers Wg Cdr V Vasdev*, Wg Cdr DS Chadha +, Gp Capt P Kharbanda #, Lt Col SK Datta**, Air Cmde RK Ganjoo AVSM VSM ++ ABSTRACT
More informationLeft ventricular non-compaction: the New Cardiomyopathy on the Block
Left ventricular non-compaction: the New Cardiomyopathy on the Block Aamir Jeewa MB BCh, FAAP, FRCPC Section Head, Cardiomyopathy & Heart Function Program The Hospital for Sick Children Assistant Professor
More information